• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.

作者信息

Nørgaard-Pedersen B, Schultz H P, Arends J, Brincker H, Krag Jacobsen G, Lindeløv B, Rørth M, Svennekjaer I L

出版信息

Acta Radiol Oncol. 1984;23(4):287-94. doi: 10.3109/02841868409136024.

DOI:10.3109/02841868409136024
PMID:6208749
Abstract

Since Jan. 1, 1976, nearly all new cases of testicular germ cell tumours have been included in the Danish Testicular Carcinoma Study (DATECA), and have been monitored by the tumour markers alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG). During the first five years, 1058 patients participated in the investigation, but only 603 of these patients were followed by preoperative as well as postoperative marker determinations in serum. The overall prevalence of marker positivity, i.e. elevated preoperative values for AFP and/or HCG, was 8 per cent for seminoma patients and 60 per cent for non-seminoma patients. Elevated levels of serum AFP and HCG were correlated to the presence of endodermal sinus tumour and choriocarcinoma elements, respectively, in the primary tumour. The presence of increased marker concentration in serum was correlated stage (higher percentage in higher stages) and to prognosis (marker negative patients had a better prognosis than marker positive patients). Marker production by seminoma patients seems to indicate a poor prognosis, especially for HCG producing seminomas.

摘要

相似文献

1
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Acta Radiol Oncol. 1984;23(4):287-94. doi: 10.3109/02841868409136024.
2
Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.与组织学和分期相关的睾丸生殖细胞肿瘤的生化标志物:1976年至1981年丹麦睾丸癌(DATECA)研究的一些经验。
Ann N Y Acad Sci. 1983;417:390-9. doi: 10.1111/j.1749-6632.1983.tb32881.x.
3
Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.评估五种肿瘤标志物(甲胎蛋白、癌胚抗原、人绒毛膜促性腺激素、人胎盘催乳素和妊娠相关血浆蛋白A)在监测睾丸生殖细胞肿瘤患者的治疗及随访中的作用。
Oncology. 1983;40(1):1-10. doi: 10.1159/000225681.
4
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.睾丸生殖细胞肿瘤中的甲胎蛋白(AFP)和人绒毛膜促性腺激素(HCG)。肿瘤标志物的组织学和血清学出现情况比较。
Acta Pathol Microbiol Immunol Scand A. 1983 May;91(3):183-90. doi: 10.1111/j.1699-0463.1983.tb02744.x.
5
[Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].人胎盘碱性磷酸酶(hPLAP)是睾丸癌中最常升高的血清标志物。
Aktuelle Urol. 2011 Sep;42(5):311-5. doi: 10.1055/s-0031-1271545. Epub 2011 Aug 1.
6
Prognostic factors in testicular germ cell tumours. Experiences from 1058 consecutive cases.睾丸生殖细胞肿瘤的预后因素。1058例连续病例的经验。
Acta Radiol Oncol. 1984;23(4):271-85. doi: 10.3109/02841868409136023.
7
Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.影响肿瘤标志物升高的化疗难治性生殖细胞癌患者挽救性手术结果的因素。
Cancer. 2003 Oct 15;98(8):1635-42. doi: 10.1002/cncr.11711.
8
Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.肿瘤标志物分析在预后不良的转移性非精原细胞性生殖细胞肿瘤中的预后意义
Eur J Cancer. 1993;29A(7):961-5. doi: 10.1016/s0959-8049(05)80202-3.
9
Applications of biologic tumor markers in testicular cancer.生物肿瘤标志物在睾丸癌中的应用。
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1643-7.
10
Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?性腺外表现是否会使腹部生殖细胞肿瘤的预后更差?
Eur J Cancer. 1992;28A(4-5):825-8. doi: 10.1016/0959-8049(92)90123-j.

引用本文的文献

1
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.睾丸肿瘤:血清 microRNA-371a-3p (M371) 水平与组织学、临床分期和年龄的经典肿瘤标志物之间的相互关系——一项统计学分析。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7079-7090. doi: 10.1007/s00432-023-04664-8. Epub 2023 Mar 4.
2
Biomarkers of disease recurrence in stage I testicular germ cell tumours.I 期睾丸生殖细胞肿瘤疾病复发的生物标志物。
Nat Rev Urol. 2022 Nov;19(11):637-658. doi: 10.1038/s41585-022-00624-y. Epub 2022 Aug 26.
3
Improving outcomes in germ cell cancers using miRNA.
利用微小RNA改善生殖细胞癌的治疗效果。
Ther Adv Med Oncol. 2021 Jun 30;13:17588359211027826. doi: 10.1177/17588359211027826. eCollection 2021.
4
Testicular germ cell tumors type 2 have high RNA expression of , the gene for lactate dehydrogenase subunit B.睾丸生殖细胞肿瘤 2 型的乳酸脱氢酶亚基 B 基因的 RNA 表达水平较高。
Asian J Androl. 2021 Jul-Aug;23(4):357-362. doi: 10.4103/aja.aja_4_21.
5
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.持续性升高的甲胎蛋白与恶性卵巢生殖细胞肿瘤化疗期间的慢性乙型肝炎相关:病例系列及文献复习。
J Ovarian Res. 2019 Dec 13;12(1):124. doi: 10.1186/s13048-019-0598-x.
6
Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.血清肿瘤标志物在睾丸生殖细胞肿瘤中的应用:升高的频率和标志物升高的程度与临床参数显著相关,并与治疗反应相关。
Biomed Res Int. 2019 May 28;2019:5030349. doi: 10.1155/2019/5030349. eCollection 2019.
7
Treatment of stage I seminoma: should beta-HCG positive seminoma be treated aggressively?I期精原细胞瘤的治疗:β-HCG阳性的精原细胞瘤是否应积极治疗?
Int Urol Nephrol. 1998;30(5):593-8. doi: 10.1007/BF02550551.
8
Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.血清β-HCG升高的睾丸精原细胞瘤——一种介于精原细胞瘤和非精原细胞瘤之间的生殖细胞癌类型。
Int Urol Nephrol. 1989;21(2):175-84. doi: 10.1007/BF02550806.
9
Optimal drug therapy in the treatment of testicular cancer.睾丸癌治疗中的最佳药物疗法。
Drugs. 1991 Jul;42(1):52-64. doi: 10.2165/00003495-199142010-00004.
10
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.非精原细胞性生殖细胞肿瘤患者血清肿瘤标志物监测的频率
Br J Cancer. 1990 Jun;61(6):916-8. doi: 10.1038/bjc.1990.205.